Anaplastic Astrocytoma — Trials

Anaplastic Astrocytoma — Trials · CancerIndex

Clinical trials

Registered studies

209 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 37
Recruiting: 22
Ph III recruiting: 2
Growth YoY: —
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 41.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (45)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01861990	Valproic Acid in Childhood Progressive Brain Tumors	withdrawn	Phase 1	0	Medical University of South CarolinaOTHER	1	May 22, 2015	clinicaltrials
NCT02055196	Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas	withdrawn	Phase 1	0	City of Hope Medical CenterOTHER	1	Jun 2, 2014	clinicaltrials